Antipsychotics versus no Antipsychotics for children and adolescents with ASD | ||||||
---|---|---|---|---|---|---|
Patient or Population: children and adolescents with ASD Setting: Inpatients and Outpatients Intervention: Antipsychotics Control: no Antipsychotics | ||||||
Outcomes | Anticipated absolute effectsa (95% CI) | Relative effect (95% CI) | № of participants (studies) | Certainty of the evidence (GRADE) | Comments | |
Risk with no Antipsychotics | Risk with Antipsychotics | |||||
Discontinuation due to any cause (Follow up: median 8 weeks) | 244 per 1.000 | 149 per 1.000 (117 to 190) | RR 0.61 (0.48 to 0.78) | 1124 (15 RCT) [33,34,35,36,37,38,39,40,41,42,43,44,45,46,47] | ⨁⨁⨁◯ MODERATE b | Antipsychotics probably reduce the risk of dropout due to any cause |
Discontinuation due to adverse events (Follow up: median 8 weeks) | 39 per 1.000 | 39 per 1.000 (22 to 70) | RR 0.99 (0.55 to 1.79) | ⨁⨁◯◯ LOW a,b | Antipsychotics may result in little to no difference in the risk of dropout due to adverse events |